Skip to Content
You are currently on the new version of our website. Access the old version .

4,628 Results Found

  • Article
  • Open Access
1 Citations
2,240 Views
22 Pages

2 September 2025

Tuberculosis, the deadliest human lung disease caused by Mycobacterium tuberculosis, continues to be a global health threat, and finding new drugs and drug targets seems an ongoing battle. The cytochrome P450 CYP125A1 enzyme of M. tuberculosis H37Rv,...

(This article belongs to the Section Molecular Informatics)
  • Article
  • Open Access
42 Citations
6,770 Views
13 Pages

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity

  • Mirza Bojić,
  • Martin Kondža,
  • Hrvoje Rimac,
  • Goran Benković and
  • Željan Maleš

1 September 2019

Cytochromes P450 are major metabolic enzymes involved in the biotransformation of xenobiotics. The majority of xenobiotics are metabolized in the liver, in which the highest levels of cytochromes P450 are expressed. Flavonoids are natural compounds t...

(This article belongs to the Section Natural Products Chemistry)
  • Article
  • Open Access
4 Citations
4,948 Views
27 Pages

Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes

  • Lauren Varney,
  • Stephen Murtough,
  • Marius Cotic,
  • Rosemary Abidoph and ,
  • Lian Chan,
  • Noushin Saadullah Khani,
  • Alvin Richards-Belle,
  • Maria Richards-Brown,
  • Daisy Mills and
  • Elvira Bramon
  • + 45 authors+ 40 authors

Background/Objectives: Antipsychotic treatment response varies considerably between individuals, with one potential reason being genetic variation affecting the cytochrome P450 enzymes that metabolise them. Methods: With a diverse sample of 453 parti...

(This article belongs to the Special Issue Recent Advances in Psychopharmacology)
  • Article
  • Open Access
4 Citations
2,040 Views
14 Pages

16 November 2024

CYP3As are important drug-metabolizing enzymes in the liver. The causes for large inter-person variability in CYP3A expression/activity remain poorly understood. DNA methylation broadly regulates gene expression and the developmental transition from...

  • Article
  • Open Access
109 Citations
14,398 Views
20 Pages

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

  • Miriam Saiz-Rodríguez,
  • Susana Almenara,
  • Marcos Navares-Gómez,
  • Dolores Ochoa and ,
  • Manuel Román,
  • Pablo Zubiaur,
  • Dora Koller,
  • María Santos,
  • Gina Mejía and
  • Francisco Abad-Santos
  • + 7 authors+ 2 authors

Several cytochrome P450 (CYP) CYP3A polymorphisms were associated with reduced enzyme function. We aimed to evaluate the influence of these alleles on the pharmacokinetic parameters (PK) of several CYP3A substrates. We included 251 healthy volunteers...

(This article belongs to the Section Molecular and Translational Medicine)
  • Article
  • Open Access
5 Citations
3,148 Views
11 Pages

Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients

  • Marielle M. Macêdo,
  • Anne C. G. Almeida,
  • Gabrielly S. Silva,
  • Amanda C. Oliveira and ,
  • Victor I. Mwangi,
  • Ana C. Shuan,
  • Laila R. A. Barbosa,
  • Fernanda Rodrigues-Soares and
  • Gisely C. Melo
  • + 4 authors+ 0 author

In the Amazon, the treatment for Plasmodium vivax is chloroquine plus primaquine. However, this regimen is limited due to the risk of acute hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency. Primaquine is a prodrug that requires conver...

  • Article
  • Open Access
9 Citations
3,287 Views
22 Pages

Cytochromes CYP1A1, CYP1A2, and CYP1B1, the members of the cytochrome P450 family 1, catalyze the metabolism of endogenous compounds, drugs, and non-drug xenobiotics which include substances involved in the process of carcinogenesis, cancer chemoprev...

(This article belongs to the Special Issue Cancer Prevention with Molecular Target Therapies 3.0)
  • Article
  • Open Access
11 Citations
3,797 Views
12 Pages

Afro-Latin American Pharmacogenetics of CYP2D6, CYP2C9, and CYP2C19 in Dominicans: A Study from the RIBEF-CEIBA Consortium

  • Mariela Guevara,
  • Fernanda Rodrigues-Soares,
  • Carla González de la Cruz,
  • Fernando de Andrés and ,
  • Ernesto Rodríguez,
  • Eva Peñas-Lledó,
  • Adrián LLerena and
  • CEIBA Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF
  • + 3 authors+ 0 author

Background/Objectives: Research on pharmacogenetic variability in response to prescribed drugs and across ethnic groups is essential for personalized medicine, particularly in admixed and unstudied populations. For the first time, this study examines...

  • Article
  • Open Access
4 Citations
2,881 Views
11 Pages

Background: It is believed that alterations in the functioning of the cytochrome P450 (CYP), which participates in metabolic transformations of endogenous polyunsaturated fatty acids (PUFAs) (with the formation of cardioprotective or cardiotoxic prod...

(This article belongs to the Special Issue Animal Models for the Study of Cardiovascular Physiology)
  • Article
  • Open Access
19 Citations
11,081 Views
19 Pages

CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity

  • Ferenc Fekete,
  • Katalin Mangó,
  • Annamária Minus,
  • Katalin Tóth and
  • Katalin Monostory

CYP1A2, one of the most abundant hepatic cytochrome P450 enzymes, is involved in metabolism of several drugs and carcinogenic compounds. Data on the significance of CYP1A2 genetic polymorphisms in enzyme activity are highly inconsistent; therefore, t...

(This article belongs to the Special Issue Association Studies in Clinical Pharmacogenetics)
  • Review
  • Open Access
98 Citations
12,747 Views
52 Pages

The Role of CYP3A in Health and Disease

  • Lyubov S. Klyushova,
  • Maria L. Perepechaeva and
  • Alevtina Y. Grishanova

CYP3A is an enzyme subfamily in the cytochrome P450 (CYP) superfamily and includes isoforms CYP3A4, CYP3A5, CYP3A7, and CYP3A43. CYP3A enzymes are indiscriminate toward substrates and are unique in that these enzymes metabolize both endogenous compou...

(This article belongs to the Special Issue Cytochrome P450 (CYP) in Health and Disease)
  • Article
  • Open Access
5 Citations
3,761 Views
11 Pages

22 January 2023

Carbamazepine (CBZ), a commonly prescribed antiepileptic drug, in human liver, is mainly metabolized by two isoforms of cytochrome P450 (CYP), CYP3A4 and CYP3A5. Therefore, the binding of CBZ with these two enzymes plays crucial role in the biotransf...

(This article belongs to the Special Issue The Interplay among Biomolecules and Nanomaterials)
  • Article
  • Open Access
614 Views
22 Pages

CYP3A4, CYP3A5, and CYP4F2 Polymorphisms and Bleeding Risk in Ticagrelor-Based Dual Antiplatelet Therapy

  • Sonja Dakić,
  • Zoran Perišić,
  • Svetlana Apostolović,
  • Tomislav Kostić and ,
  • Goran Koraćević,
  • Tatjana Jevtović,
  • Boris Đinđić,
  • Nikola Stefanović,
  • Danijela Đorđević-Radojković and
  • Tamara Filipović
  • + 9 authors+ 4 authors

22 June 2026

Background and Objectives: Ticagrelor reduces ischemic events in acute coronary syndrome (ACS) but increases bleeding risk. Clinical predictors of bleeding are well established; the contribution of cytochrome P450 polymorphisms involved in ticagrelor...

(This article belongs to the Special Issue Advances in Acute Myocardial Infarction)
  • Article
  • Open Access
507 Views
18 Pages

Genetic Polymorphisms CYP3A4*22, CYP3A5*3, and CYP2D6 Predicted Phenotypes Are Not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders

  • Dmitriy V. Ivashchenko,
  • Mikhail D. Che,
  • Farid R. Aysin,
  • Svetlana N. Tuchkova and ,
  • Ivan N. Korsakov,
  • Ekaterina I. Ianavichiute,
  • Mariia A. Ivashchenko,
  • Pavel V. Shimanov,
  • Rimma V. Kondratieva and
  • Dmitry A. Sychev
  • + 8 authors+ 3 authors

4 September 2026

Objectives. To identify associations between CYP3A4*22 and CYP3A5*3 genotypes, CYP2D6 phenotype, and the effectiveness and safety of antipsychotics in neurotypically developed boys with conduct disorders. Methods: The study included neurotypically de...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
5 Citations
2,432 Views
16 Pages

Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study

  • Mohamed Abouzid,
  • Łukasz Kruszyna,
  • Dominika Kaczmarek,
  • Leonid Kagan and ,
  • Aniceta Ada Mikulska-Sauermann,
  • Dorota Filipowicz,
  • Matylda Resztak,
  • Franciszek K. Główka and
  • Marta Karaźniewicz-Łada
  • + 4 authors+ 0 author

The active form of vitamin D, calcitriol (1,25(OH)2D3), is produced from 25(OH)D3 via enzymes encoded by CYP2R1, CYP27A1, and CYP27B1. Polymorphisms in these genes may alter vitamin D metabolism and increase cardiovascular disease risk. This prelimin...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
18 Citations
9,377 Views
22 Pages

The antiplatelet agent clopidogrel is listed by the FDA as a strong clinical index inhibitor of cytochrome P450 (CYP) 2C8 and weak clinical inhibitor of CYP2B6. Moreover, clopidogrel is a substrate of—among others—CYP2C19 and CYP3A4. This...

(This article belongs to the Special Issue Drug–Drug Interactions (Volume II))
  • Article
  • Open Access
5 Citations
3,648 Views
14 Pages

Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs

  • David Damoiseaux,
  • Wenlong Li,
  • Alejandra Martínez-Chávez,
  • Jos H. Beijnen and ,
  • Alfred H. Schinkel,
  • Alwin D. R. Huitema and
  • Thomas P. C. Dorlo
  • + 2 authors+ 0 author

The extrapolation of drug exposure between species remains a challenging step in drug development, contributing to the low success rate of drug approval. As a consequence, extrapolation of toxicology from animal models to humans to evaluate safe, fir...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
6 Citations
1,721 Views
5 Pages

2 October 2013

Background and Objective. VKORC1, CYP2C9, and CYP4F2 are known to be responsible for the metabolism of warfarin. The aim was to explore the frequencies of these genotypes in the Russian population and compare the results with those for other populati...

  • Review
  • Open Access
22 Citations
12,189 Views
11 Pages

Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review

  • Kenza Mansoor,
  • Razan Bardees,
  • Bayan Alkhawaja,
  • Eyad Mallah and ,
  • Luay AbuQatouseh,
  • Mathias Schmidt and
  • Khalid Matalka
  • + 2 authors+ 0 author

24 February 2023

The Punica granatum L. (pomegranate) fruit juice contains large amounts of polyphenols, mainly tannins such as ellagitannin, punicalagin, and punicalin, and flavonoids such as anthocyanins, flavan-3-ols, and flavonols. These constituents have high an...

(This article belongs to the Section Food Chemistry)
  • Article
  • Open Access
7 Citations
7,970 Views
11 Pages

Artemisia annua L. Extracts Irreversibly Inhibit the Activity of CYP2B6 and CYP3A4 Enzymes

  • Martin Kondža,
  • Marta Mandić,
  • Ivona Ivančić,
  • Sanda Vladimir-Knežević and
  • Ivica Brizić

Artemisia annua L. has long been known for its medicinal properties and isolation of ingredients whose derivatives are used for therapeutic purposes. The CYP2B6 and CYP3A4 enzymes belong to a large family of cytochrome P450 enzymes. These enzymes are...

(This article belongs to the Special Issue Cytochrome P450 (CYP) in Health and Disease)
  • Article
  • Open Access
8 Citations
5,183 Views
10 Pages

CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort

  • Hristo Y. Ivanov,
  • Denitsa Grigorova,
  • Volker M. Lauschke,
  • Branimir Velinov and ,
  • Kaloyan Stoychev,
  • Gergana Kyosovska and
  • Peter Shopov
  • + 2 authors+ 0 author

21 July 2022

CYP2D6 and CYP2C19 are enzymes of essential significance for the pharmacokinetics of a multitude of commonly used antidepressants, antipsychotics, antiemetics, β-blockers, opioids, antiestrogen, antacids, etc. Polymorphisms in the respective gen...

(This article belongs to the Section Omics/Informatics)
  • Systematic Review
  • Open Access
20 Citations
5,787 Views
23 Pages

Polymorphisms in VDR, CYP27B1, CYP2R1, GC and CYP24A1 Genes as Biomarkers of Survival in Non-Small Cell Lung Cancer: A Systematic Review

  • Laura Elena Pineda-Lancheros,
  • José María Gálvez-Navas,
  • Susana Rojo-Tolosa,
  • Cristina Membrive-Jiménez and ,
  • María Isabel Valverde-Merino,
  • Fernando Martínez-Martínez,
  • Almudena Sánchez-Martín,
  • MCarmen Ramírez-Tortosa,
  • Cristina Pérez-Ramírez and
  • Alberto Jiménez-Morales
  • + 5 authors+ 0 author

21 March 2023

The objective of this systematic review was to provide a compilation of all the literature available on the association between single-nucleotide polymorphisms (SNPs) in the genes involved in the metabolic pathway of vitamin D and overall survival (O...

(This article belongs to the Section Nutrigenetics and Nutrigenomics)
  • Article
  • Open Access
2 Citations
2,556 Views
14 Pages

Influence of CYP2D6, CYP2C19, and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish Patients

  • Levin Thomas,
  • Carla González de la Cruz,
  • Carmen Mata-Martín,
  • Idian González-Rodríguez and ,
  • Idilio González-Martínez,
  • Eva M. Peñas-Lledó and
  • Adrián LLerena
  • + 2 authors+ 0 author

26 January 2026

Background/Objectives: Venlafaxine has been reported to exhibit significant interindividual pharmacokinetic heterogeneity across populations, which has been linked to cytochrome P450 polymorphisms and clinical factors. This study aimed to assess the...

(This article belongs to the Topic Pharmacokinetic and Pharmacodynamic Modelling in Drug Discovery and Development, 2nd Edition)
  • Article
  • Open Access
2 Citations
1,767 Views
14 Pages

CYP2C:TG Haplotype in Native Mexicans, Molecular Ancestry and Its Implications for CYP2C19 Genotype–Phenotype Correlation

  • Carla González de la Cruz,
  • Nadine de Godoy Torso,
  • Juan Antonio Villatoro-García,
  • Carmen Mata-Martín and ,
  • Fernanda Rodrigues-Soares,
  • Carlos Galaviz-Hernández,
  • Eva Peñas-Lledó,
  • Martha Sosa-Macías,
  • Adrián LLerena and
  • RIBEF-IBEROFEN Consortium
  • + 5 authors+ 0 author

19 December 2025

Background: Recent studies have associated the presence of the CYP2C:TG haplotype with increased metabolism of CYP2C19 substrates such as escitalopram and sertraline, suggesting a potential regulatory interaction between CYP2C18 and CYP2C19. However,...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
15 Citations
6,152 Views
10 Pages

The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression

  • Julian Maciaszek,
  • Tomasz Pawłowski,
  • Tomasz Hadryś,
  • Marta Machowska and ,
  • Anna Wiela-Hojeńska and
  • Błażej Misiak
  • + 1 author+ 0 author

30 August 2023

Depression is a global mental health concern, and personalized treatment approaches are needed to optimize its management. This study aimed to investigate the influence of the CYP2D6 and CYP1A2 gene polymorphisms on the efficacy of duloxetine in redu...

(This article belongs to the Special Issue Molecular Pharmacology of Antidepressants)
  • Communication
  • Open Access
20 Citations
6,303 Views
9 Pages

The Effects of H2S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat

  • Xianqin Wang,
  • Anyue Han,
  • Congcong Wen,
  • Mengchun Chen and ,
  • Xinxin Chen,
  • Xuezhi Yang,
  • Jianshe Ma and
  • Guanyang Lin
  • + 3 authors+ 0 author

10 December 2013

Hydrogen sulfide (H2S) is a colorless, flammable, extremely hazardous gas with a “rotten egg” smell. The human body produces small amounts of H2S and uses it as a signaling molecule. The cocktail method was used to evaluate the influence of H2S on th...

(This article belongs to the Section Molecular Toxicology)
  • Article
  • Open Access
36 Citations
4,933 Views
11 Pages

26 September 2020

Background: Helicobacter pylori eradication containing the potassium-competitive acid blocker, vonoprazan, achieves a higher eradication rate than therapy with proton pump inhibitors (PPIs). Because vonoprazan is mainly metabolized by CYP3A4/5, CYP g...

(This article belongs to the Special Issue How to Optimize the Use of Antibiotics in Human and Animal Health Care? – A Time to Act)
  • Article
  • Open Access
2 Citations
2,007 Views
25 Pages

Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus

  • Adiel Ortega-Ayala,
  • Carla González de la Cruz,
  • Lorena Mora,
  • Mauro Bonilla and ,
  • Leandro Tana,
  • Fernanda Rodrigues-Soares,
  • Pedro Dorado,
  • Adrián LLerena and
  • Enrique Terán
  • + 4 authors+ 0 author

5 September 2025

Background/Objectives: In Ecuador, the prevalence of type 2 diabetes mellitus (T2DM) is the second leading cause of death after ischemic heart disease. Genetic variability in protein-coding genes, single nucleotide variants (SNVs), influences the res...

(This article belongs to the Special Issue Advancements in Cardiovascular and Antidiabetic Drug Therapy, 2nd Edition)
  • Article
  • Open Access
9 Citations
5,110 Views
12 Pages

Involvement of CYP51A and CYP51B in Growth, Reproduction, Pathogenicity, and Sensitivity to Fungicides in Colletotrichum siamense

  • Shuodan Hu,
  • Jianyan Wu,
  • Xiaoqi Yang,
  • Wenfei Xiao and ,
  • Hong Yu and
  • Chuanqing Zhang
  • + 1 author+ 0 author

13 January 2023

Strawberry crown rot is a serious fungal disease that poses a great threat to strawberry production in the growth cycle. The dominant pathogens of strawberry crown rot pathogens were different in different periods. The main pathogen of strawberry cro...

(This article belongs to the Special Issue Plant Anthracnose: Etiology and Current Management Options)
  • Article
  • Open Access
2 Citations
1,963 Views
24 Pages

The metabolism of drugs and foreign substances in humans typically involves multiple enzymatic steps, particularly in phase-1 biotransformation in the liver, where various cytochrome P450 monooxygenases (CYPs) play crucial roles. This complexity can...

(This article belongs to the Special Issue Cytochrome P450: Metabolism, Structure-Function, Evolution and Applications)
  • Article
  • Open Access
6 Citations
6,797 Views
10 Pages

Changes in Alprazolam Metabolism by CYP3A43 Mutants

  • Jie Zhao,
  • Sijie Liu,
  • Clemens Alexander Wolf,
  • Gerhard Wolber and ,
  • Maria Kristina Parr and
  • Matthias Bureik
  • + 1 author+ 0 author

23 November 2022

Alprazolam is a triazolobenzodiazepine which is most commonly used in the short-term management of anxiety disorders, often in combination with antipsychotics. The four human members of the CYP3A subfamily are mainly responsible for its metabolism, w...

(This article belongs to the Special Issue Antipsychotics: 70 Years)
  • Article
  • Open Access
17 Citations
7,464 Views
12 Pages

Effects of Flavonoids in Lysimachia clethroides Duby on the Activities of Cytochrome P450 CYP2E1 and CYP3A4 in Rat Liver Microsomes

  • Zhi-Juan Zhang,
  • Zhao-Yang Xia,
  • Jin-Mei Wang,
  • Xue-Ting Song and ,
  • Jin-Feng Wei and
  • Wen-Yi Kang
  • + 1 author+ 0 author

Incubation systems were established to investigate the effects of quercetin, kaempferol, isoquercitrin and astragalin in Lysimachia clethroides Duby on the activities of CYP2E1 and CYP3A4 in rat liver microsomes in vitro. Probe substrates of 4-nitrop...

(This article belongs to the Collection Bioactive Compounds)
  • Article
  • Open Access
6 Citations
192 Views
5 Pages

Porcine Foetal and Neonatal CYP3A Liver Expression

  • Marie Louise Hiort Hermann and
  • Mette Tingleff Skaanild
J. Xenobiotics2011, 1(1), e1;https://doi.org/10.4081/xeno.2011.e1 
(registering DOI)

6 May 2011

Human cytochrome P450 3A7 (CYP3A7) and cytochrome P450 3A4 (CYP3A4) are hepatic metabolising enzymes which participates in the biotransformation of endo- and exogenous substances in foetuses and neonates respectively. These CYP3A enzymes display an i...

  • Article
  • Open Access
28 Citations
6,284 Views
17 Pages

The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics

  • Isabelle Austin-Zimmerman,
  • Marta Wronska,
  • Baihan Wang,
  • Haritz Irizar and ,
  • Johan H. Thygesen,
  • Anjali Bhat,
  • Spiros Denaxas,
  • Ghazaleh Fatemifar,
  • Chris Finan and
  • Elvira Bramon
  • + 10 authors+ 5 authors

3 November 2021

CYP2D6 and CYP2C19 enzymes are essential in the metabolism of antidepressants and antipsychotics. Genetic variation in these genes may increase risk of adverse drug reactions. Antidepressants and antipsychotics have previously been associated with ri...

(This article belongs to the Special Issue Advances in Genetics of Psychiatric Disorders)
  • Article
  • Open Access
5 Citations
2,804 Views
15 Pages

15 January 2021

One possible way to overcome the diversity of toxic plant allelochemicals idiosyncratically distributed among potential host plants is to have more counterdefense genes via gene duplication or fewer gene losses. Cytochrome P450 is the most important...

(This article belongs to the Section Insect Molecular Biology and Genomics)
  • Article
  • Open Access
6 Citations
5,178 Views
13 Pages

28 January 2022

Genotyping of the CYP2D6 gene is the most commonly applied pharmacogenetic test globally. Significant economic interests have led to the development of a plurality of assays, available for almost any genotyping platform or DNA detection chemistry. Of...

(This article belongs to the Special Issue Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy: Future Perspectives)
  • Article
  • Open Access
18 Citations
6,698 Views
12 Pages

Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes—A Link in the Onset and Development of Cardiovascular Disease?

  • Benoit Drolet,
  • Sylvie Pilote,
  • Carolanne Gélinas,
  • Alida-Douce Kamaliza and ,
  • Audrey Blais-Boilard,
  • Jessica Virgili,
  • Dany Patoine and
  • Chantale Simard
  • + 3 authors+ 0 author

Arachidonic acid can be metabolized by cytochrome P450 (CYP450) enzymes in a tissue- and cell-specific manner to generate vasoactive products such as epoxyeicosatrienoic acids (EETs-cardioprotective) and hydroxyeicosatetraenoic acids (HETEs-cardiotox...

(This article belongs to the Special Issue Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape)
  • Article
  • Open Access
1 Citations
2,527 Views
14 Pages

Identification of New Substrates and Inhibitors of Human CYP2A7

  • Rana Azeem Ashraf,
  • Sijie Liu,
  • Clemens Alexander Wolf,
  • Gerhard Wolber and
  • Matthias Bureik

CYP2A7 is one of the most understudied human cytochrome P450 enzymes and its contributions to either drug metabolism or endogenous biosynthesis pathways are not understood, as its only known enzymatic activities are the conversions of two proluciferi...

  • Article
  • Open Access
5 Citations
1,576 Views
23 Pages

Pharmacokinetics of CYP2C19- and CYP3A4-Metabolized Drugs in Cirrhosis Using a Whole-Body PBPK Approach

  • Ruijing Mu,
  • Jingjing Gao,
  • Xiaoli Wang,
  • Jing Ling and ,
  • Nan Hu and
  • Hanyu Yang
  • + 1 author+ 0 author

Background/Objectives: Cirrhosis significantly alters physiological function and drug metabolism, particularly for medications primarily metabolized by CYP2C19 and CYP3A4. This study aims to establish a physiologically based pharmacokinetic (PBPK) mo...

(This article belongs to the Special Issue Recent Advances in Physiologically Based Pharmacokinetics)
  • Article
  • Open Access
4 Citations
1,979 Views
25 Pages

Molecular Ancestry Across Allelic Variants of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Mexican-Mestizo DMT2 Patients

  • Adiel Ortega-Ayala,
  • Carla González de la Cruz,
  • Pedro Dorado,
  • Fernanda Rodrigues-Soares and ,
  • Fernando Castillo-Nájera,
  • Adrián LLerena and
  • Juan Molina-Guarneros
  • + 2 authors+ 0 author

Background/Aims: across protein-coding genes, single nucleotide allelic variants (SNVs) affect antidiabetic drug pharmacokinetics, thus contributing to interindividual variability in drug response. SNV frequencies vary across different populations. S...

(This article belongs to the Special Issue Diabetes: Comorbidities, Therapeutics and Insights (2nd Edition))
  • Article
  • Open Access
7 Citations
11,311 Views
11 Pages

Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects

  • Natalia Guevara,
  • Cecilia Maldonado,
  • Manuel Uría,
  • Raquel González and ,
  • Manuel Ibarra,
  • Silvana Alvariza,
  • Antonella Carozzi,
  • Carlos Azambuja,
  • Pietro Fagiolino and
  • Marta Vázquez
  • + 5 authors+ 0 author

18 August 2017

Phenytoin (PHT) oxidative route leads to its main metabolite p-hydroxyphenytoin (p-HPPH), by means of CYP2C9 and CYP2C19. Formation of p-HPPH proceeds via a reactive arene-oxide intermediate. This intermediate can also be converted into PHT dihydrodi...

(This article belongs to the Special Issue Epilepsy and Neurodegeneration: Current Therapeutic Implications)
  • Article
  • Open Access
2 Citations
3,960 Views
15 Pages

A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1, and VKORC1 Genes

  • Camille Tron,
  • Régis Bouvet,
  • Marie-Clémence Verdier,
  • Fabien Lamoureux and ,
  • Benjamin Hennart,
  • Christèle Dubourg,
  • Eric Bellissant and
  • Marie-Dominique Galibert
  • + 3 authors+ 0 author

In the field of pharmacogenetics, the trend is to analyze a panel of several actionable genetic polymorphisms. It may require the use of high-throughput sequencing which demands expensive reagents/instruments and specific skills to interpret results....

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
34 Citations
4,653 Views
17 Pages

Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study

  • Barbara Altieri,
  • Silviu Sbiera,
  • Sabine Herterich,
  • Silvia De Francia and ,
  • Silvia Della Casa,
  • Anna Calabrese,
  • Alfredo Pontecorvi,
  • Marcus Quinkler,
  • Tina Kienitz and
  • Cristina L. Ronchi
  • + 12 authors+ 7 authors

4 February 2020

Mitotane is the only approved drug for advanced adrenocortical carcinoma (ACC) and no biomarkers are available to predict attainment of therapeutic plasma concentrations and clinical response. Aim of the study was to evaluate the suitability of cytoc...

(This article belongs to the Special Issue Adrenocortical Carcinoma)
  • Article
  • Open Access
16 Citations
4,917 Views
15 Pages

Genotype of Null Polymorphisms in Genes GSTM1, GSTT1, CYP1A1, and CYP1A1*2A (rs4646903 T>C)/CYP1A1*2C (rs1048943 A>G) in Patients with Larynx Cancer in Southeast Spain

  • Mariano Sánchez-Siles,
  • Juan Pablo Pelegrín-Hernández,
  • Diego Hellin-Meseguer,
  • Yolanda Guerrero-Sánchez and ,
  • Andrés Corno-Caparrós,
  • Juan Cabezas-Herrera,
  • Francisco Pastor-Quirante,
  • Juan Alberto Fernández-Ruiz,
  • Alfonso Aliaga-Sánchez and
  • Fabio Camacho-Alonso
  • + 6 authors+ 1 author

1 September 2020

Background: some types of cancer have been associated with the presence of single nucleotide polymorphisms (SNPs) of some genes that encode enzymes: glutathione-S transferase (GST), whose alteration leads to loss of function and a lower capacity to e...

  • Article
  • Open Access
1 Citations
1,559 Views
18 Pages

Association Between CYP2C9 and CYP2C19 Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy

  • Angel T. Alvarado,
  • Felipe L. Ignacio-Cconchoy,
  • Juan C. Espinoza-Retuerto,
  • Roxana M. Contreras-Macazana and ,
  • Luis Abel Quiñones,
  • Jorge A. García,
  • María R. Bendezú,
  • Haydee Chávez,
  • Felipe Surco-Laos and
  • Nelson M. Varela
  • + 14 authors+ 9 authors

9 December 2025

Background/Objectives: Epilepsy is characterized by recurrent, unprovoked, self-limiting seizures of genetic, acquired, or unknown origin. It affects more than 50 million people worldwide. The prevalence in Peru is 11.9–32.1 per 1000 people. Ou...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
5 Citations
2,978 Views
14 Pages

Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine–Norfluoxetine Pharmacokinetics in Real-World Clinical Conditions

  • Carla González de la Cruz,
  • Levin Thomas,
  • Carmen Mata-Martín,
  • Idian González and ,
  • Adrián LLerena and
  • Eva M. Peñas-Lledó
  • + 1 author+ 0 author

Background: Fluoxetine, a widely prescribed selective serotonin reuptake inhibitor, exhibits significant interindividual variability in pharmacokinetics, largely attributed to pharmacogenomic factors. Objectives: The study aimed to evaluate the impac...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
36 Citations
5,459 Views
16 Pages

Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation

  • Kimitaka Suetsugu,
  • Yasuo Mori,
  • Nanae Yamamoto,
  • Tomohiro Shigematsu and ,
  • Toshihiro Miyamoto,
  • Nobuaki Egashira,
  • Koichi Akashi and
  • Satohiro Masuda
  • + 3 authors+ 0 author

Single nucleotide polymorphisms in drug-metabolizing genes may affect tacrolimus pharmacokinetics. Here, we investigated the influence of genotypes of CYP3A5, CYP2C19, and POR on the concentration/dose (C/D) ratio of tacrolimus and episodes of acute...

(This article belongs to the Special Issue Molecular Mechanisms and Biomarkers in Drug-Induced Organ Injury)
  • Article
  • Open Access
4 Citations
2,695 Views
13 Pages

CYP3A and CYP2B6 Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study

  • Wondmagegn Tamiru Tadesse,
  • Eulambius Mathias Mlugu,
  • Workineh Shibeshi,
  • Wondwossen Amogne Degu and ,
  • Ephrem Engidawork and
  • Eleni Aklillu
  • + 1 author+ 0 author

30 June 2022

Long-term antiretroviral treatment (cART) increases the risk of glucose metabolism disorders (GMDs). Genetic variation in drug-metabolizing enzymes and transporters may influence susceptibility to cART-associated GMDs. We conducted a case-control stu...

(This article belongs to the Section Pharmacogenetics)
  • Article
  • Open Access
6 Citations
9,402 Views
12 Pages

Effect of Nicotine on CYP2B1 Expression in a Glioma Animal Model and Analysis of CYP2B6 Expression in Pediatric Gliomas

  • Sonia Nava-Salazar,
  • Saúl Gómez-Manzo,
  • Jaime Marcial-Quino,
  • Alfonso Marhx-Bracho and ,
  • Bryan V. Phillips-Farfán,
  • Carlos Diaz-Avalos and
  • America Vanoye-Carlo
  • + 2 authors+ 0 author

Cyclophosphamide (CPA) is a pro-drug commonly used in the chemotherapeutic schemes for glioma treatment but has high toxicity and the side effects include brain damage and even death. Since CPA is activated mainly by CY2B6, over-expression of the enz...

(This article belongs to the Special Issue Cytochromes P450: Drug Metabolism and Bioactivation)
  • Article
  • Open Access
11 Citations
3,307 Views
13 Pages

10 August 2021

The small brown planthopper, Laodelphax striatellus (Fallén), is an important agricultural pest that causes significant losses by sucking and transmitting multiple plant viruses, such as rice black-streaked dwarf virus (RBSDV). Insecticides are commo...

(This article belongs to the Special Issue State-of-the-Art Plant-Virus Interactions in Asia)

of 93